Abcam (ABC) Upgraded at Peel Hunt

Share on StockTwits

Peel Hunt upgraded shares of Abcam (LON:ABC) to a buy rating in a research note issued to investors on Wednesday morning. Peel Hunt currently has GBX 1,330 ($17.38) target price on the stock, down from their previous target price of GBX 1,350 ($17.64).

Other equities research analysts have also issued research reports about the stock. Berenberg Bank restated a buy rating and issued a GBX 1,640 ($21.43) target price on shares of Abcam in a report on Tuesday. Numis Securities restated a hold rating on shares of Abcam in a report on Tuesday, September 11th. Finally, JPMorgan Chase & Co. restated a neutral rating on shares of Abcam in a report on Wednesday, January 2nd.

Abcam stock opened at GBX 1,216 ($15.89) on Wednesday. Abcam has a 12-month low of GBX 9.73 ($0.13) and a 12-month high of GBX 1,290 ($16.86).

In related news, insider Jonathan Simon Milner purchased 187,790 shares of Abcam stock in a transaction that occurred on Thursday, December 6th. The shares were bought at an average price of GBX 1,060 ($13.85) per share, with a total value of £1,990,574 ($2,601,037.50). Also, insider Suzanne Smith purchased 864 shares of Abcam stock in a transaction that occurred on Wednesday, November 7th. The stock was bought at an average cost of GBX 1,219 ($15.93) per share, for a total transaction of £10,532.16 ($13,762.13).

About Abcam

Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays.

See Also: Stochastic Momentum Index (SMI)

Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Advisors Capital Management LLC Buys New Stake in PRA Health Sciences Inc
Advisors Capital Management LLC Buys New Stake in PRA Health Sciences Inc
Advisors Capital Management LLC Boosts Position in Public Service Enterprise Group Inc.
Advisors Capital Management LLC Boosts Position in Public Service Enterprise Group Inc.
Addison Capital Co Has $833,000 Holdings in Philip Morris International Inc.
Addison Capital Co Has $833,000 Holdings in Philip Morris International Inc.
Advisors Capital Management LLC Takes Position in Becton Dickinson and Co
Advisors Capital Management LLC Takes Position in Becton Dickinson and Co
Allen Capital Group LLC Grows Holdings in Johnson & Johnson
Allen Capital Group LLC Grows Holdings in Johnson & Johnson
Zacks Investment Research Lowers Orange  to Sell
Zacks Investment Research Lowers Orange to Sell


Leave a Reply

© 2006-2019 Ticker Report